Riparian Pharmaceuticals Overview
Update this profile
Latest Deal Type
Riparian Pharmaceuticals General Information Description
Developer of therapeutics designed to improve endothelial function to reduce vascular complications. The company's therapeutics target new vasoprotective pathways to treat both prevalent and serious rare vascular diseases at an early stage, enabling physicians to have improved patient outcomes.
Riparian Pharmaceuticals Timeline
Financing Round Financing Round Captured Employee Count Estimated Employee Growth
Want to dig into this profile?
We’ll help you find what you need
Riparian Pharmaceuticals Valuation & Funding
Raised to Date
7. Later Stage VC (Series A2)
6. Later Stage VC (Series A1)
To view Riparian Pharmaceuticals’s complete valuation and funding history, request access »
Riparian Pharmaceuticals Signals
0.80%, 93rd %ile
219x, 100th %ile
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial